通过成咨询服务的医院基的甲和布普伦诺芬启动实践
Shawn M Cohen1,2, Elana Straus3, David A Fiellin1,2,3,4,5
1Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut.
临床医生正在通过使用快速甲和各种布普伦诺芬启动实践来适应对高强度合成阿片类药物的响应,以医院为基础的阿片类药物使用障碍治疗. 这些新的方法往往先于研究和指南更新.
科学领域:
- 成 药物 药物 药物 药物
- 临床药理学 临床药理学
- 公共卫生 公共卫生
背景情况:
- 高强度合成阿片类药物 (HPSO) 复杂化阿片类药物使用障碍 (OUD) 的治疗开始.
- 已经出现了用于甲和布普伦诺芬启动的新型医院实践.
- 缺乏对这些新实践的国家特征.
研究的目的:
- 评估新型医院实践的采用和性质,以启动甲和布普伦诺芬.
- 了解HPSO对这些启动实践的感知影响.
主要方法:
- 对美国医院成咨询服务 (ACS) 负责人的横截面调查.
- 通过REDcap匿名调查从2023年10月到2024年4月收集的数据.
- 评估的做法包括标准的,快速的甲启动,以及各种布普伦诺芬启动策略 (低剂量,高剂量,传统,救援).
主要成果:
- 72.5%的ACS董事完成了调查.
- 81.0%的受访者开始使用甲,而70.2%的HPSO报告改变了他们的做法.
- 87.0%的人报告使用快速甲启动,93.1%的人同意HPSO影响了布普伦诺芬启动.
- 所有受访者都提供了布普伦诺芬的启动,低剂量是最常见的,除了重大戒断的情况下.
结论:
- 基于医院的成咨询服务正在适应甲和布普伦诺芬的启动,以适应不断变化的合成阿片类药物供应.
- 当前的实践往往超过现有的研究和临床指南.
- 需要进一步的研究来评估这些新的启动策略的有效性和安全性.
更多相关视频
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drug Abuse and Addiction: Pharmacological Phenomena
Specialized Care Centers and Settings-II
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Drug Dependence
